Provider-Reviewed vs Self-Directed Optimization
Provider-reviewed optimization is anchored to a standardized biomarker panel, licensed provider review in the candidate's state, and longitudinal continuity. Self-directed protocols lack panel discipline, licensing, and safety adjudication. oMeds operates exclusively as the provider-reviewed pathway.
Provider-reviewed optimization is the only pathway oMeds supports — required for safe, longitudinal results.
Explore pathwaySelf-directed protocols are outside the oMeds model and outside regulated medicine.
Educational. Final pathway selection is provider-reviewed via synchronous video consultation against your biomarkers, history, and goals.
Frequently asked
Why is synchronous provider review required?
It is required by telemedicine law and by safe-prescribing standards.
Can I optimize without a panel?
Not at oMeds — the panel is the standardized read across every pathway.
Take the optimization assessment.
The adaptive assessment maps your symptoms, history, and goals to candidate pathways — and routes you into provider review.
Begin assessment